中药抗病毒性心肌炎实验进展  

Experiment Progress in TCM Treatment for Viral Myocarditis

作　　者：张璇 徐晶钰[1] 孙大志[1] 裴蓓[1] 张慈安[1] 秦志丰[1] 

机构地区：[1]第二军医大学附属长征医院,上海200003

出　　处：《中国中医药信息杂志》2015年第11期131-133,共3页Chinese Journal of Information on Traditional Chinese Medicine

基　　金：上海市科委项目(11DZ1971302)

摘　　要：病毒性心肌炎(VMC)是常见的病毒感染导致的心肌炎性病变,目前西医治疗主要以对症支持为主,而临床上运用中医药治疗该病疗效显著。本文主要从VMC常见的4种机制入手,分别阐述中药单体或复方制剂具有抗病毒、调节免疫、抗自由基、抗氧化、改善心肌代谢、保护心肌细胞等作用,为临床上中药的运用提供实验依据。Viral myocarditis(VMC) is normally caused by myocarditis virus infection. Currently, the Western medicine treatment is mainly about symptomatic supportive treatment, while TCM has remarkable efficacy for this disease. This article started from the 4 common mechanisms of VMC, and elaborated the effects of individual and compound preparation, such as antiviral, regulating immune, anti free redical, antioxidation, improving myocardial metabolism, protecting myocardial cells, with a purpose to provide experimental references for TCM application in clinic.

关 键 词：病毒性心肌炎 中药 实验研究 综述 

分 类 号：R259.422.11[医药卫生—中西医结合]